Cargando…

Home visiting to an HIV positive patient prior to initiation of HAART has Lasting impact on their adherence. TASO Experience

Detalles Bibliográficos
Autores principales:	Odeke, Emmanuel, Nyatia, Ricky Jones, Sekiranda, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315939/ http://dx.doi.org/10.1186/1742-4690-7-S1-P155

Ejemplares similares

Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda
por: Abaasa, Andrew M, et al.
Publicado: (2008)

Perceived quality of clinical Care provided by nurses to people living with HIV at Four TASO sites in Uganda
por: Mugisha, Kenneth, et al.
Publicado: (2010)

High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan
por: Salami, O, et al.
Publicado: (2010)

With out a quality management tool, all HIV Managers shall not realise any steps forward for improvement: a Taso Uganda experience
por: Mpiima, Denis, et al.
Publicado: (2010)

Characteristic of HIV/AIDS infected patients at the detection and HAART initiation
por: Holban, Tiberiu, et al.
Publicado: (2014)

Improving retention and HIV viral load suppression among adolescents living with HIV in TASO Soroti and TASO Mbale centers of excellence using Operation Triple Zero model: a before and after study protocol
por: Oryokot, Bonniface, et al.
Publicado: (2023)

High preterm delivery rates associated with initiation of HAART during pregnancy
por: Taylor, GP, et al.
Publicado: (2010)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Does feedback of medication execution using MEMS caps aid adherence to HAART?: the MEMRI study (MEMS as Realistic Intervention)
por: Davies, S, et al.
Publicado: (2010)

Factors associated with non-adherence to HAART in HIV-positive pregnant women during pregnancy, peri- and postpartum in Lima, Peru
por: Tejada, Romina, et al.
Publicado: (2010)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Impact of timing HAART initiation on immune status and clinical course in the cohort of the German competence network for HIV/AIDS
por: Plettenberg, A, et al.
Publicado: (2010)

Impact of short term HAART initiated during the acute or chronic stage on SIV infection of the male genital tract
por: Moreau, Marina, et al.
Publicado: (2010)

Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment
por: Perez-Molina, JA, et al.
Publicado: (2010)

The prognosis of patients with dissociated virological and immunological responses to HAART
por: Jevtovic, DJ, et al.
Publicado: (2010)

Effective HAART reduces the incidence of high grade cervical neoplasia in HIV positive women
por: Morris-Harris, Deborah, et al.
Publicado: (2012)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

Mesenteric fat thickness in a group of HIV patients on HAART
por: Lee, SS, et al.
Publicado: (2010)

Rethinking the “Pre” in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs
por: Siedner, Mark J., et al.
Publicado: (2012)

Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure
por: Sanchez, Carlos Alberto, et al.
Publicado: (2010)

Factors associated with treatment modification during the first year of contemporary HAART
por: Martin, N, et al.
Publicado: (2010)

Last Visit to Hospitals
Publicado: (1920)

Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: A retrospective cohort study
por: Opito, Ronald, et al.
Publicado: (2020)

Semen may harbor HIV despite effective HAART: another piece in the puzzle
por: Halfon, Philippe, et al.
Publicado: (2010)

Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
por: Kojic, EM, et al.
Publicado: (2009)

Physician home visits to rostered patients during their last year of life: a retrospective cohort study
por: Scott, Mary M., et al.
Publicado: (2023)

Use of once-daily raltegravir-based HAART in HIV-infected injection drug users
por: Tossonian, HK, et al.
Publicado: (2010)

Five-year outcomes of HAART at a non-governmental treatment center in Lima, Peru
por: Castillo, N, et al.
Publicado: (2010)

Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007
por: Metcalfe, John, et al.
Publicado: (2010)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Adherence to HAART: Africans Take Medicines More Faithfully than North Americans
por: Attaran, Amir
Publicado: (2007)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort
por: Lifson, Alan R, et al.
Publicado: (2012)

Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART
por: Uglietti, A, et al.
Publicado: (2010)

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds
por: Pironti, A, et al.
Publicado: (2010)

Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era
por: Madeddu, G, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_liru717ug9e9j1mujgu7iav5lt